Patent · US Expired

Polymorphs of an epothilone analog

US6982276B2 · kind B2 · utility

7Cited by
6References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 6, 2004
Grant dateJan 3, 2006
Priority date
Expiry dateJun 30, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D417/06
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

There are provided in accordance with the present invention two crystalline polymorphs, designated Form A and Form B, respectively, as well as mixtures thereof, of an epothilone analog represented by the formula Also provided are methods of forming the novel polymorphs, therapeutic methods utilizing them and pharmaceutical dosage forms containing them.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.